Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
|
K TRON INTERNATIONAL INC (KTII)
|
Add to portfolio |
|
|
|
| Price: |
$150.01
| | Metrics |
| OS: |
2.84
|
M
| |
14
|
% ROE
|
| Market cap: |
$426
|
M
| |
38
|
% ROIC
|
|
Net cash:
|
$54.6
|
M
| |
$19.24
|
per share
|
|
EV:
|
$371
|
M
| | | |
| | | | | |
| TTM Valuation | | | |
|
EBITDA
|
$35.9
|
M
| |
10.3
|
x EV/EBITDA
|
|
EBIT
|
$29.9
|
M
| |
12.4
|
x EV/EBIT
|
| EPS |
$13.49
| |
11.1
|
x P/E
|
|
|
| |
|
|
|
Recent News + Filings (All items)
|
Revenue Mix by Segment
|
Financial Summary (All financials)
| In millions, except per share items | Jan-02-10 | Jan-03-09 | Dec-29-07 | Dec-30-06 | Dec-31-05 | Jan-01-05 | Jan-03-04 | Dec-28-02 |
| Revenues | 190.8 | 243.0 | 201.7 | 148.1 | 118.9 | 112.5 | 94.7 | 68.2 |
| Revenue growth | -21.5% | 20.5% | 36.2% | 24.5% | 5.7% | 18.8% | 38.8% | -5.0% |
| Cost of goods sold | 109.5 | 141.6 | 115.4 | 85.8 | 68.9 | 66.1 | 55.9 | 39.4 |
| Gross profit | 81.3 | 101.4 | 86.2 | 62.3 | 50.0 | 46.4 | 38.8 | 28.9 |
| Gross margin | 42.6% | 41.7% | 42.8% | 42.1% | 42.0% | 41.2% | 41.0% | 42.3% |
| Selling, general and administrative | 49.5 | 60.9 | 52.0 | 39.6 | 34.3 | 33.8 | 29.2 | 21.5 |
| Research and development | 1.9 | 2.5 | 2.4 | 2.3 | 2.4 | 2.7 | 2.7 | 2.4 |
| EBIT | 29.9 | 38.0 | 31.9 | 20.4 | 13.2 | 9.7 | 6.8 | 4.9 |
| EBIT margin | 15.7% | 15.6% | 15.8% | 13.8% | 11.1% | 8.6% | 7.2% | 7.2% |
| Pre-tax income | 31.9 | 37.0 | 30.1 | 19.4 | 12.2 | 8.7 | 5.2 | 4.4 |
| Income taxes | 10.4 | 11.2 | 8.8 | 6.5 | 4.9 | 2.1 | 1.5 | 1.1 |
| Tax rate | 32.5% | 30.3% | 29.3% | 33.6% | 40.3% | 24.3% | 29.0% | 25.3% |
| Net income | 21.6 | 25.8 | 21.3 | 12.9 | 7.3 | 6.6 | 3.7 | 3.3 |
| Net margin | 11.3% | 10.6% | 10.6% | 8.7% | 6.1% | 5.9% | 3.9% | 4.8% |
| |
| Diluted EPS | $7.64 | $9.37 | $7.93 | $4.95 | $2.85 | $2.65 | $1.53 | $1.35 |
| Shares outstanding (diluted) | 2.8 | 2.8 | 2.7 | 2.6 | 2.6 | 2.5 | 2.4 | 2.4 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|
|